Stay updated on Pembrolizumab & Radiation for Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation for Lymphoma Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.6.5 appears, replacing the previous Revision: v3.6.4. This indicates a software update to the page without altering study details.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 in the page footer. This signals a deployment/version update of the page template.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the page, indicating a minor update to the page template or content. This change does not modify study details or results.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's revision tag in the metadata was updated from v3.6.0 to v3.6.2, indicating a newer release of the underlying page system. This change does not modify visible content or user interactions.SummaryDifference0.1%

- Check61 days agoChange DetectedEnrollment status now indicates recruitment is closed. New navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label updates, along with the revision history change from v3.5.5 to v3.6.0, have been added.SummaryDifference0.4%

- Check68 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a small update to the page's documentation/versioning.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Radiation for Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.